Try our Advanced Search for more refined results

Pozen's Suit Over Treximet ANDAs Stays Intact

By Samuel Howard (October 15, 2010, 4:18 PM EDT) -- The judge overseeing Pozen Inc.'s bench trial against Par Pharmaceutical Cos. Inc., Mylan Inc.'s Alphapharm Pty. Ltd. and Dr. Reddy's Laboratories Inc. over generic versions of the migraine treatment Treximet denied the defendants any telling victories Thursday, leaving the parties to wait to find out if the market for the drug will be thrown open....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!